# Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine

> **NCT05158855** · NA · COMPLETED · sponsor: **DreamTec Research Limited** · enrollment: 16 (actual)

## Conditions studied

- COVID-19 Pandemic

## Interventions

- **DIETARY_SUPPLEMENT:** Bacillus subtilis spore extract

## Key facts

- **NCT ID:** NCT05158855
- **Lead sponsor:** DreamTec Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-04-20
- **Final completion:** 2022-04-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158855, "Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT05158855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*